POST-MARKETING SURVEILLANCE - DRUG EPIDEMIOLOGY

被引：12
|
作者：
BORDEN, EK
机构：
来源：
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH | 1981年 / 9卷 / 06期
关键词：
D O I：
10.1177/030006058100900602
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：401 / 407
页数：7
相关论文
共 50 条
  • [31] Hemangiol in infantile haemangioma: A paediatric post-marketing surveillance drug study
    Socchi, Floriane
    Bigorre, Michele
    Normandin, Marion
    Captier, Guillaume
    Bessis, Didier
    Mondain, Michel
    Blanchet, Catherine
    Akkari, Mohamed
    Amedro, Pascal
    Gavotto, Arthur
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (04) : 1970 - 1980
  • [32] Post-marketing surveillance of escitalopram in depressed outpatients
    Möller, HJ
    Lotze, K
    Lange, S
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S428 - S428
  • [33] Challenges and perspectives in surveillance of post-marketing/use
    Fontenele Martins, Mary Anne
    Coelho Penna Teixeira, Ana Paula
    VIGILANCIA SANITARIA EM DEBATE-SOCIEDADE CIENCIA & TECNOLOGIA, 2019, 7 (04): : 3 - 9
  • [34] A Clustering Ensemble Method for Drug Safety Signal Detection in Post-Marketing Surveillance
    Chakraborty, Shubhadeep
    Tiwari, Ram
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2025, 59 (01) : 89 - 101
  • [35] Distributed, collaborative intelligent agents for proactive post-marketing drug safety surveillance
    Ji, Yanqing
    Ying, Hao
    Farber, Margo S.
    Yen, John
    Dews, Peter
    Miller, Richard E.
    Massanari, R. Michael
    NAFIPS 2007 - 2007 ANNUAL MEETING OF THE NORTH AMERICAN FUZZY INFORMATION PROCESSING SOCIETY, 2007, : 158 - +
  • [36] INFORMATION-SYSTEM FOR POST-MARKETING DRUG SURVEILLANCE SCHEME ON SMALL COMPUTERS
    MOUSSA, MAA
    METHODS OF INFORMATION IN MEDICINE, 1982, 21 (04) : 181 - 186
  • [37] Utility of electronic health records to support post-marketing drug safety surveillance
    Lin, Nancy D.
    Calderbank, Jenna
    Anderson, David
    Seeger, John
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 415 - 415
  • [38] Drug-induced Neuropsychiatric Adverse Events Using Post-Marketing Surveillance
    Wakabayashi, Tomohito
    Nakatsuji, Takahiro
    Kambara, Hiroko
    Niinomi, Iku
    Oyama, Saki
    Inada, Ayaka
    Ueno, Sayaka
    Uchida, Mayako
    Iwanaga, Kazunori
    Iida, Tatsuya
    Hosohata, Keiko
    CURRENT REVIEWS IN CLINICAL AND EXPERIMENTAL PHARMACOLOGY, 2022, 17 (02) : 144 - 148
  • [39] Role of the Post-Marketing Authorisation Studies in Drug Risk Surveillance: Specifications and Methodologies
    Tubach, Florence
    Lamarque-Garnier, Veronique
    Castot, Anne
    THERAPIE, 2011, 66 (04): : 355 - 362
  • [40] A Temporal Interestingness Measure for Drug Interaction Signal Detection in Post-marketing Surveillance
    Ji, Yanqing
    Ying, Hao
    Tran, John
    Dews, Peter
    Mansour, Ayman
    Massanari, R. Michael
    2014 36TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY (EMBC), 2014, : 2722 - 2725
12345